DE68924319T2 - Als therapeutische mittel verwendbare substituierte adeninderivate. - Google Patents

Als therapeutische mittel verwendbare substituierte adeninderivate.

Info

Publication number
DE68924319T2
DE68924319T2 DE68924319T DE68924319T DE68924319T2 DE 68924319 T2 DE68924319 T2 DE 68924319T2 DE 68924319 T DE68924319 T DE 68924319T DE 68924319 T DE68924319 T DE 68924319T DE 68924319 T2 DE68924319 T2 DE 68924319T2
Authority
DE
Germany
Prior art keywords
aden
substituted
therapeutic agents
derivatives used
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68924319T
Other languages
English (en)
Other versions
DE68924319D1 (de
Inventor
Dennis Carson
Carlos Carrera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Application granted granted Critical
Publication of DE68924319D1 publication Critical patent/DE68924319D1/de
Publication of DE68924319T2 publication Critical patent/DE68924319T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/19—Purine radicals with arabinosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Table Equipment (AREA)
DE68924319T 1988-03-16 1989-03-16 Als therapeutische mittel verwendbare substituierte adeninderivate. Expired - Lifetime DE68924319T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16961888A 1988-03-16 1988-03-16
US32335089A 1989-03-14 1989-03-14
PCT/US1989/001088 WO1989008658A1 (en) 1988-03-16 1989-03-16 Substituted adenine derivatives useful as therapeutic agents

Publications (2)

Publication Number Publication Date
DE68924319D1 DE68924319D1 (de) 1995-10-26
DE68924319T2 true DE68924319T2 (de) 1996-05-15

Family

ID=26865224

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68924319T Expired - Lifetime DE68924319T2 (de) 1988-03-16 1989-03-16 Als therapeutische mittel verwendbare substituierte adeninderivate.

Country Status (9)

Country Link
EP (1) EP0364559B1 (de)
JP (1) JP3090456B2 (de)
KR (1) KR0138996B1 (de)
AT (1) ATE128141T1 (de)
AU (1) AU626296B2 (de)
CA (1) CA1339964C (de)
DE (1) DE68924319T2 (de)
FI (1) FI895447A0 (de)
WO (1) WO1989008658A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5384310A (en) * 1989-05-23 1995-01-24 Southern Research Institute 2'-fluoro-2-haloarabinoadinosines and their pharmaceutical compositions
US5034518A (en) * 1989-05-23 1991-07-23 Southern Research Institute 2-fluoro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl) adenine nucleosides
US5420115A (en) * 1990-09-10 1995-05-30 Burroughs Wellcome Co. Method for the treatment of protoza infections with 21 -deoxy-21 -fluoropurine nucleosides
AU1254892A (en) * 1990-12-18 1992-07-22 Sloan-Kettering Institute For Cancer Research Novel synthesis of 2'-"up" fluorinated 2''-deoxy-arabinofuranosylpurines
GB9301000D0 (en) * 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
IL108524A0 (en) * 1993-02-03 1994-05-30 Gensia Inc Imidazodiazepine analogs
CA2191230C (en) * 1994-05-26 2001-02-27 Dennis A. Carson 2-halo-2'-deoxyadenosine treatment for inflammatory bowel disease
AU735319B2 (en) * 1994-05-26 2001-07-05 Scripps Research Institute, The 2-halo-2'-deoxyadenosine treatment for inflammatory bowel disease
US5559114A (en) * 1994-12-16 1996-09-24 Exley; Ray W. Treatment of autoimmune disease using 2-amino purine derivatives
DE19832519A1 (de) * 1998-07-20 2000-01-27 Hartmut Oswald Arzneimittelzubereitungen zur topischen Behandlung mukokutaner Herpesinfektionen sowie der Keratitis herpetica des Auges
AU2001238516B2 (en) * 2000-02-18 2005-08-04 Southern Research Institute Methods for synthesizing 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H- purin-6-amine
US7528247B2 (en) 2001-08-02 2009-05-05 Genzyme Corporation Process for preparing purine nucleosides
WO2004029025A2 (en) 2002-09-27 2004-04-08 Bioenvision, Inc. Methods and compositions for the treatment of autoimmune disorders using clofarabine
WO2004028463A2 (en) * 2002-09-27 2004-04-08 Bioenvision, Inc. Methods and compositions for the treatment of lupus using clofarabine
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
JP6510621B2 (ja) * 2017-11-29 2019-05-08 華安醫學股分有限公司Ｅｎｅｒｇｅｎｅｓｉｓ Ｂｉｏｍｅｄｉｃａｌ Ｃｏ．， Ｌｔｄ． 活性化ａｍｐｋの化合物及びその使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539550A (en) * 1967-01-23 1970-11-10 Syntex Corp Process for the preparation of 2'-halo-2'-deoxy pyrimidine nucleosides
US3472838A (en) * 1967-12-01 1969-10-14 Parke Davis & Co 9 - (beta - d - arabinofuranosyl) - 6 - (amidino) purine compounds and methods for their production
BE759011A (fr) * 1969-11-17 1971-05-17 Wellcome Found Aminopurines
GB1386585A (en) * 1970-11-16 1975-03-12 Wellcome Found Purine sugar derivatives
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
GB8708050D0 (en) * 1987-04-03 1987-05-07 Wellcome Found Therapeutic nucleosides
CA1340645C (en) * 1987-04-17 1999-07-13 Victor E. Marquez Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus
EP0314011A3 (de) * 1987-10-30 1990-04-11 F. Hoffmann-La Roche Ag Purinderivate

Also Published As

Publication number Publication date
FI895447A0 (fi) 1989-11-15
JP3090456B2 (ja) 2000-09-18
AU626296B2 (en) 1992-07-30
AU3410589A (en) 1989-10-05
JPH03501258A (ja) 1991-03-22
CA1339964C (en) 1998-07-21
WO1989008658A1 (en) 1989-09-21
KR0138996B1 (ko) 1998-04-30
EP0364559A4 (en) 1991-01-09
EP0364559A1 (de) 1990-04-25
DE68924319D1 (de) 1995-10-26
ATE128141T1 (de) 1995-10-15
KR900700495A (ko) 1990-08-13
EP0364559B1 (de) 1995-09-20

Similar Documents

Publication Publication Date Title
DE68924319D1 (de) Als therapeutische mittel verwendbare substituierte adeninderivate.
FI943805A0 (fi) Substituoituja adeniinijohdannaisten käyttö multippeliskleroosin hoitoon
DE3774918D1 (de) Cancerostatisches mittel.
ATE319474T1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
DE3854741D1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
DZ1469A1 (fr) Nouveaux dérivés chromanne et thiochromanne.
DK254887D0 (da) Salve til behandling af hudsygdomme
DK71387A (da) Terapeutisk middel til behandling af psoriasis
ATE78465T1 (de) Kathartica.
ATE69953T1 (de) Verwendung von polysulfatierten heparinen.
ES507807A0 (es) Procedimiento para la obtencion de derivados triciclicos de citosina.
DK23289A (da) Disubstituerede pyridinderivater, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
DK621487D0 (da) Fremgangsmaade til oegning af adenosinexkretion
FR2419291A1 (fr) 2,3-dihydroimidazo(1,2-c)pyrimidines substituees et leur utilisation therapeutique
ZA873928B (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
NO161494C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive benzodiazepiner.
DK572189A (da) Substituerede adeninderivater og farmaceutisk praeparat indeholdende dem
YU169090A (sh) Tetra hidroimidazo (1,4) benzodiazepini
BE904444A (fr) Derives condenses de thiazoles 2-substitues.
DE68926743D1 (de) Die freisetzung des histamin hemmenden faktors sowie diesen enthaltende präparate
SE8202433L (sv) Linkomycin-3-(5'-ribonukleotider)lempade for behandling av protosoriska sjukdomar

Legal Events

Date Code Title Description
8364 No opposition during term of opposition